ImmucellAktie

ISIN: US4525253062 | WKN: 885825 | Symbol: IUL
4,640
 
EUR
08:13:18 Frankfurt
-0,43 %
-0,020 EUR
Geldkurs 08:27:31
4,640 EUR
3.000 Stk.
Briefkurs 08:27:31
4,760 EUR
3.000 Stk.
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
DURCHBRUCH für Biotech-Aktie! Klinische Studie ist auf dem Weg zur medizinischen Revolution! Investieren Sie in den Marktführer!

Immucell Chart

Neuigkeiten zur Immucell Corp Aktie

ZeitTitel
SmartbrokerJetzt auf smartbroker.de - ab 0 € pro Order handeln! Anzeige
06.08.20
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020
07.07.20
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
16.06.20
ImmuCell Receives $500,000 Loan from the Maine Technology
14.05.20
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
13.05.20
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020
07.05.20
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020
14.04.20
ImmuCell Receives $938,000 in Support under the Paycheck Protection Program
02.04.20
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
11.03.20
ImmuCell Announces Refinancing of its Bank Debt
19.02.20
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
18.02.20
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
13.02.20
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019
21.01.20
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Nachrichten aus der Branche Biotechnologie

ZeitTitel
13:30 Uhr
BioElectronics Chairman Outlines New Direction for Company
13:30 Uhr
Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business Update
13:30 Uhr
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
13:05 Uhr
Axsome Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
13:05 Uhr
New Study Shows Screening Based on Self-Reported Ethnicity Fails to Identify Significant Percentage of Pregnancies Affected by Serious Genetic Conditions
mehr Branchennachrichten »

Aktienkurs Immucell 885825 |

BörsenplatzFrankfurt
Letzter Kurs4,640EUR
Performance-0,43 %
Kurszeit08:13:18
Eröffnung4,640EUR
Tageshoch4,640EUR
Tagestief4,640EUR
Vortageskurs4,660EUR
52-Wochen Hoch5,600EUR
52-Wochen Tief3,440EUR
Performance 1 Monat+1,30 %
Performance 1 Jahr-10,98 %

Stammdaten zu Immucell

NameImmucell Corp
KurznameImmucell
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKN885825
SymbolIUL
BrancheBiotechnologie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl7,21 Mio.
Marktkapitalisierung33,47 Mio.EUR

Performance Immucell Aktie

ZeitKursPerf.
1 Tag4,640EUR
-0,43 %
1 Woche4,760EUR
-2,10 %
1 Monat4,600EUR
+1,30 %
3 Monate4,140EUR
+12,56 %
6 Monate4,420EUR
+5,43 %
Lfd. Jahr4,320EUR
+7,87 %
1 Jahr5,235EUR
-10,98 %
3 Jahre6,029EUR
-22,71 %
5 Jahre8,941EUR
-47,88 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameImmucell Corp
StadtPortland
LandUSA USA
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Evotec
+1,12
2.
Myriad Genetics
-0,86
3.
Spectrum Pharmaceuticals
-1,21
4.
Teva Pharmaceutical Industries
-0,20
5.
KemPharm
+1,88
6.
Proteostasis Therapeutics
-0,99
7.
Generex Biotechnology
-7,86
8.
AIM ImmunoTech
+2,36
9.
Aveo Pharmaceuticals
-0,90
10.
InMed Pharmaceuticals
-7,29

Handelsinformationen

Haupthandel09:00 - 20:00 Uhr
Liquidister HandelsplatzNasdaq